Authors: | Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; Landau, H.; Roshal, M.; Dogan, A.; Giralt, S. A.; Mastey, D.; Evancha, N.; Devlin, S. M.; Landgren, O. |
Abstract Title: | MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone |
Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 130 |
Issue: | Suppl. 1 |
Meeting Dates: | 2017 Dec 9-12 |
Meeting Location: | Atlanta, GA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2017-12-07 |
Language: | English |
ACCESSION: | WOS:000432419700333 |
PROVIDER: | wos |
DOI: | 10.1182/blood.V130.Suppl_1.3133.3133 |
Notes: | Meeting Abstract: 3133 -- Source: Wos |